Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 42% ± 14% | |
peripheral blood | 16 studies | 35% ± 11% | |
intestine | 12 studies | 35% ± 17% | |
eye | 10 studies | 36% ± 16% | |
kidney | 9 studies | 34% ± 12% | |
brain | 9 studies | 26% ± 8% | |
liver | 5 studies | 33% ± 20% | |
lymph node | 5 studies | 40% ± 12% | |
pancreas | 4 studies | 61% ± 12% | |
bone marrow | 4 studies | 26% ± 7% | |
uterus | 4 studies | 46% ± 13% | |
prostate | 4 studies | 39% ± 17% | |
breast | 4 studies | 38% ± 6% | |
placenta | 3 studies | 58% ± 9% | |
adrenal gland | 3 studies | 32% ± 11% | |
esophagus | 3 studies | 57% ± 28% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 8858.63 | 1445 / 1445 | 100% | 161.41 | 183 / 183 |
ovary | 100% | 5209.11 | 180 / 180 | 100% | 200.78 | 430 / 430 |
intestine | 100% | 7362.14 | 966 / 966 | 100% | 105.43 | 526 / 527 |
stomach | 100% | 5166.87 | 359 / 359 | 100% | 112.42 | 285 / 286 |
breast | 100% | 4956.80 | 459 / 459 | 100% | 83.88 | 1114 / 1118 |
uterus | 100% | 4878.05 | 170 / 170 | 100% | 108.99 | 457 / 459 |
skin | 100% | 6836.14 | 1808 / 1809 | 100% | 77.15 | 470 / 472 |
bladder | 100% | 6758.57 | 21 / 21 | 99% | 83.97 | 501 / 504 |
lung | 99% | 4631.01 | 575 / 578 | 100% | 98.56 | 1153 / 1155 |
pancreas | 99% | 3716.10 | 325 / 328 | 100% | 70.59 | 178 / 178 |
thymus | 100% | 3997.04 | 651 / 653 | 99% | 68.98 | 601 / 605 |
kidney | 100% | 5102.06 | 89 / 89 | 99% | 73.35 | 892 / 901 |
prostate | 100% | 4128.07 | 244 / 245 | 99% | 70.22 | 498 / 502 |
brain | 98% | 4309.42 | 2601 / 2642 | 100% | 82.46 | 705 / 705 |
adrenal gland | 100% | 5831.08 | 258 / 258 | 98% | 80.37 | 226 / 230 |
liver | 81% | 1833.37 | 184 / 226 | 98% | 45.83 | 396 / 406 |
adipose | 100% | 5469.05 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 121.47 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 75.94 | 29 / 29 |
muscle | 100% | 12061.29 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3190.17 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 119.68 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 38.18 | 1 / 1 |
blood vessel | 100% | 5935.28 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 9837.10 | 833 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 84% | 3321.56 | 781 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007339 | Biological process | binding of sperm to zona pellucida |
GO_0098656 | Biological process | monoatomic anion transmembrane transport |
GO_0032272 | Biological process | negative regulation of protein polymerization |
GO_0097345 | Biological process | mitochondrial outer membrane permeabilization |
GO_0006820 | Biological process | monoatomic anion transport |
GO_2001243 | Biological process | negative regulation of intrinsic apoptotic signaling pathway |
GO_0001669 | Cellular component | acrosomal vesicle |
GO_0042645 | Cellular component | mitochondrial nucleoid |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0046930 | Cellular component | pore complex |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0097225 | Cellular component | sperm midpiece |
GO_0005634 | Cellular component | nucleus |
GO_0015288 | Molecular function | porin activity |
GO_0015485 | Molecular function | cholesterol binding |
GO_0097001 | Molecular function | ceramide binding |
GO_0008308 | Molecular function | voltage-gated monoatomic anion channel activity |
GO_0000166 | Molecular function | nucleotide binding |
GO_0031210 | Molecular function | phosphatidylcholine binding |
GO_0008142 | Molecular function | oxysterol binding |
GO_0005515 | Molecular function | protein binding |
Gene name | VDAC2 |
Protein name | Voltage-dependent anion-selective channel protein 2 (Outer mitochondrial membrane protein porin 2) Voltage-dependent anion-selective channel protein 2 (VDAC-2) (hVDAC2) (Outer mitochondrial membrane protein porin 2) |
Synonyms | hCG_23984 |
Description | FUNCTION: Forms a channel through the mitochondrial outer membrane that allows diffusion of small hydrophilic molecules (By similarity). The channel adopts an open conformation at low or zero membrane potential and a closed conformation at potentials above 30-40 mV (By similarity). The open state has a weak anion selectivity whereas the closed state is cation-selective (By similarity). Binds various lipids, including the sphingolipid ceramide, the phospholipid phosphatidylcholine, and the sterols cholesterol and oxysterol . Binding of ceramide promotes the mitochondrial outer membrane permeabilization (MOMP) apoptotic pathway . . |
Accessions | ENST00000447677.5 ENST00000298468.9 Q5JSD2 ENST00000344036.8 A0A024QZT0 ENST00000413289.1 ENST00000313132.8 [P45880-1] ENST00000543351.5 [P45880-3] Q5JSD1 A0A0A0MR02 ENST00000332211.11 [P45880-3] P45880 A2A3S1 |